Tofacitinib for a Child with Refractory Steroid-Dependent Ulcerative Colitis: A Case Report and Review of the Literature

Refaa Alajmi; Munirah Alabdulhadi; Ali A. Alali; Mohammad Shehab

doi:10.12659/AJCR.934460

12 November 2021 : Case report Kuwait

Tofacitinib for a Child with Refractory Steroid-Dependent Ulcerative Colitis: A Case Report and Review of the Literature

Unusual or unexpected effect of treatment, Rare disease

Refaa Alajmi^1E, Munirah Alabdulhadi^2EF, Ali A. Alali

^2E, Mohammad Shehab

^2AEF*

DOI: 10.12659/AJCR.934460

Am J Case Rep 2021; 22:e934460

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. PicturesA and B showing the rectum and sigmoid colon, respectively, before starting tofacitinib, with severe ulcerations, inflammation, loss of vascularity, pseudopolyps, and severely deformed lumen. Pictures C and D showing the rectum and sigmoid, respectively, 9 months after starting tofacitinib, with no ulcerations or erosions except for mild patchy erythema.

Back to the Article

Tofacitinib for a Child with Refractory Steroid-Dependent Ulcerative Colitis: A Case Report and Review of the Literature

Your Privacy